Phase 1 driving simulation finds bedtime GlyphAllo for major depressive disorder shows no next-morning driving impairment, while advancing allopregnanolone-based oral treatment development.
|Slideshows|April 12, 2021
The Mighty Blueberry
Author(s)Chris Aiken, MD
Studies suggest blueberries may have the power to treat depression...
Advertisement
Advertisement
Related to this article
Discuss depression care challenges, comorbidities, and new treatments—submit cases, research, or CME ideas for Psychiatric Times’ September 2026 series.
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Hearing on Psychedelic Medicine Reveals a Field Divided on the Road to Approval
2
Centanafadine For Comorbid ADHD and Anxiety: Talking New Data With John Kraus, MD, PhD
3
The Silence Between the Questions: Reflections on Adolescent Suicide Risk When Intent Is Unclear
4
New Adult ADHD Guidelines: What Resources Are Coming Soon
5